Neurogene Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	112.49	103.85	136.59	148.21	82.02	70.54
Short-Term Investments	112.91	165.17	175.82	48.95	-	-
Cash & Short-Term Investments	225.39	269.01	312.41	197.16	82.02	70.54
Cash Growth	-17.90%	-13.89%	58.45%	140.37%	16.27%	-
Other Receivables	0.43	0.46	0.65	0.6	0.99	0.79
Receivables	0.43	0.46	0.65	0.6	0.99	0.79
Prepaid Expenses	2.56	1.94	1.89	1.5	1.08	1.91
Other Current Assets	0.53	0.36	0.98	1.1	0.63	0.71
Total Current Assets	228.91	271.77	315.92	200.35	84.72	73.96
Property, Plant & Equipment	14.01	15.46	18.49	20.95	24.55	27.53
Other Long-Term Assets	1.45	1.37	1.31	1.27	-	-
Total Assets	244.36	288.6	335.73	222.57	109.27	101.49
Accounts Payable	3.29	1.95	1.34	2.6	0.63	5.63
Accrued Expenses	14.11	10.19	9.39	16.76	5.16	4.35
Current Portion of Leases	3.03	3.06	3	2.6	0.7	0.61
Other Current Liabilities	1.08	1.2	1.43	1.02	0.17	0.27
Total Current Liabilities	21.51	16.41	15.16	22.97	6.65	10.86
Long-Term Leases	5.32	6.83	9.43	12.37	3.99	4.6
Other Long-Term Liabilities	0.41	0.48	0.77	1.21	-	-
Total Liabilities	27.23	23.72	25.36	36.55	10.64	15.46
Common Stock	-	-	-	-	-	0
Additional Paid-In Capital	635.2	617.54	572.67	373.18	5.1	3.77
Retained Earnings	-418.07	-352.65	-262.3	-187.15	-150.84	-95.65
Total Common Equity	217.13	264.89	310.38	186.02	-145.74	-91.88
Shareholders' Equity	217.13	264.89	310.38	186.02	98.63	86.03
Total Liabilities & Equity	244.36	288.6	335.73	222.57	109.27	101.49
Total Debt	8.35	9.89	12.43	14.97	4.69	5.21
Net Cash (Debt)	217.05	259.12	299.98	182.19	77.33	65.34
Net Cash Growth	-17.65%	-13.62%	64.65%	135.59%	18.36%	-
Net Cash Per Share	9.85	12.15	17.08	39.12	196.01	16.13
Filing Date Shares Outstanding	20.01	15.57	14.93	12.85	5.67	4.05
Total Common Shares Outstanding	15.83	15.49	14.85	12.82	5.67	4.05
Working Capital	207.41	255.36	300.77	177.38	78.07	63.1
Book Value Per Share	13.72	17.10	20.89	14.51	-25.72	-22.68
Tangible Book Value	217.13	264.89	310.38	186.02	-145.74	-91.88
Tangible Book Value Per Share	13.72	17.10	20.89	14.51	-25.72	-22.68
Machinery	11.22	10.87	9.6	9.31	9.04	6.01
Construction In Progress	0.28	0.32	1.31	0.23	0.25	2.86
Leasehold Improvements	15.64	15.42	15.4	15.38	15.3	15.29

SEC Filings: 10-K · 10-Q